Fennec Pharmaceuticals (FENC) Shares Outstanding (Weighted Average) (2010 - 2025)

Fennec Pharmaceuticals has reported Shares Outstanding (Weighted Average) for 16 years, with the latest figure at $28.6 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 4.7% year-over-year to $28.6 million; the trailing twelve-month figure through Dec 2025 stood at $28.6 million (up 4.7% YoY), and the FY2025 full-year result was $28.6 million, up 4.7% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $28.6 million, up from $27.7 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $28.6 million in Q4 2025, with the low at $39000.0 in Q4 2021.
• Historically, Shares Outstanding (Weighted Average) has averaged $20.1 million across 5 years, with a median of $26.1 million in 2022.
• Annual changes were most pronounced in 2021 — Shares Outstanding (Weighted Average) soared 66574.36% — and 2025, when it slumped 99.45%.
• Fennec Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $39000.0 in 2021, then surged by 284.62% to $150000.0 in 2022, then changed by 0.0% to $150000.0 in 2023, then surged by 18096.0% to $27.3 million in 2024, then advanced by 4.7% to $28.6 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $28.6 million (Q4 2025), $27.7 million (Q3 2025), and $150000.0 (Q2 2025), per Business Quant data.